MarketPulse

safety profile

3 articles
BenzingaBenzinga··Prnewswire

Aethlon Medical Advances Hemopurifier Trial to Final Cohort After Safety Clearance

Aethlon Medical's Hemopurifier device advances to final clinical trial phase following positive safety review with no adverse events reported.
AEMDclinical trialoncology
The Motley FoolThe Motley Fool··Lee Samaha

Ovid Therapeutics Surges 18% on Positive Phase 1 Data for OV329 Epilepsy Drug

Ovid Therapeutics surges 18% after Phase 1 data shows OV329 epilepsy drug eliminated safety concerns. Company secures $60M to fund Phase 2 trials.
OVIDbiotechprivate placement
GlobeNewswire Inc.GlobeNewswire Inc.··Can-Fite Biopharma Ltd.

Can-Fite's Namodenoson Clears Safety Hurdle in Pancreatic Cancer Study

Can-Fite's namodenoson meets primary safety endpoint in Phase IIa pancreatic cancer trial with no new safety signals; survival data pending.
CANFclinical developmentorphan drug designation